Irbesartan/Hydrochloorthiazide Viatris 300 mg/12
As listed in the register: Irbesartan/Hydrochloorthiazide Viatris 300 mg/12,5 mg, tabletten
300 mg + 12,5 mg · tablet
- Prescription only
- Heart, blood pressure and circulation
- Active substance
- Hydrochloorthiazide + Irbesartan
- Made by
- Viatris Limited
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
Bulgaria5 matching products
European UnionNo exact match for this strength and form
Spain10 matching products
- COAPROVEL 300 mg /12,5mg · comprimido recubierto con película3 makers
- CONVERIDE 300 mg/12,5 mg · comprimido recubierto con película
- IFIRMACOMBI 300 mg irbesartan/ 12,5 mg hidroclorotiazida · comprimido recubierto con película
- IRBESARTAN HIDROCLOROTIAZIDA ZENTIVA 300 MG irbesartan/12,5 MG hidroclorotiazida · comprimido recubierto con película
- IRBESARTAN/HIDROCLOROTIAZIDA AUROVITAS 300 mg/12,5 mg · comprimido recubierto con película
- IRBESARTÁN/HIDROCLOROTIAZIDA COMBIX 300 MG/12,5 MG · comprimido recubierto con película
- IRBESARTAN/HIDROCLOROTIAZIDA TARBIS 300 mg/12,5 mg · comprimido recubierto con película
- IRBESARTAN/HIDROCLOROTIAZIDA VISO FARMACÉUTICA 300 mg Irbesartán / 12,5 mg Hidroclorotiazida · comprimido recubierto con película
Canada12 matching products
- APO-IRBESARTAN/HCTZ 300 mg + 12.5 mg · tablet
- AURO-IRBESARTAN HCT 300 mg + 12.5 mg · tablet
- AVALIDE 300 mg + 12.5 mg · tablet
- IRBESARTAN AND HYDROCHLOROTHIAZIDE 300 mg + 12.5 mg · tablet
- IRBESARTAN HCT 300 mg + 12.5 mg · tablet
- IRBESARTAN/HCTZ 300 mg + 12.5 mg · tablet
- NB-IRBESARTAN HCT 300 mg + 12.5 mg · tablet
- PENDO-IRBESARTAN-HCTZ 300 mg + 12.5 mg · tablet
SwitzerlandNo exact match for this strength and form
Details
| Made by | Viatris Limited |
|---|---|
| Active substance | Hydrochloorthiazide + Irbesartan |
| Used in | Heart, blood pressure and circulation |
| Strength | 300 mg + 12,5 mg |
| Form | tablet |
| Classification | C09DA04 · Heart, blood pressure and circulation |
| Route | oraal gebruik |
| Dispensing (as stated by the register) | Uitsluitend recept |
| Name in the register | Irbesartan/Hydrochloorthiazide Viatris 300 mg/12,5 mg, tabletten |
| RVG | 109458 |
Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician
Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.